Further delineation of BCAP31-linked intellectual disability: description of 17 new families with LoF and missense variants
暂无分享,去创建一个
M. Shaw | J. Gécz | M. Brudno | B. Knoppers | J. Hurst | K. Boycott | B. Kamien | C. V. van Karnebeek | K. Kernohan | A. Lehman | J. Morton | F. Bernier | J. N. Hartley | Christian Marshall | A. Slavotinek | A. Pini | R. Hayeems | Roberto Mendoza | J. Parboosingh | L. Villard | A. Raas-Rothschild | J. Liebelt | D. Dyment | A. Tabet | D. Heron | P. Frosk | H. Cui | C. Mignot | T. D. de Villemeur | A. Dheedene | J. Lévy | P. Yap | Renée Carroll | F. Elmslie | J. Ozmore | B. Kirmse | S. Whalen | O. Calabrese | M. Kossorotoff | E. Brischoux-Boucher | Florence Riccardi | E. Forsythe | S. C. Bastaraud | Cecile Cieuta Walti | A. Spinelli | A. Guet | Anne McCabe | J. Hartley | K. Truxal | Carroll Jennifer | Vishal Kumar | Glen M. Thomson | A. Raas‐Rothschild | M. Innes | Sara Mostafavi | Ryan Lamont | Patrick Yap | Deborah Marshall | James Dowling | Kym Michael Francois Clara David Kristin Micheil Ryan Boycott Brudno Bernier van Karnebeek Dyment K | D. Marshall
[1] T. de Ravel,et al. BCAP31-related syndrome: The first de novo report. , 2020, European journal of medical genetics.
[2] K. Yoshiura,et al. Possible mitochondrial dysfunction in a patient with deafness, dystonia, and cerebral hypomyelination (DDCH) due to BCAP31 Mutation , 2020, Molecular genetics & genomic medicine.
[3] Sha-sha Jiang,et al. Induction of Liver Steatosis in BAP31-Deficient Mice Burdened with Tunicamycin-Induced Endoplasmic Reticulum Stress , 2018, International journal of molecular sciences.
[4] Alex Chapin,et al. Expert Specification of the ACMG/AMP Variant Interpretation Guidelines for Genetic Hearing Loss , 2018, bioRxiv.
[5] B. Wang,et al. Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice[S] , 2017, Journal of Lipid Research.
[6] H. Najmabadi,et al. Copy Number Variants in Patients with Autism and Additional Clinical Features: Report of VIPR2 Duplication and a Novel Microduplication Syndrome , 2016, Molecular Neurobiology.
[7] Keith Nykamp,et al. Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria , 2017, Genetics in Medicine.
[8] N. Monfared,et al. BCAP31‐associated encephalopathy and complex movement disorder mimicking mitochondrial encephalopathy , 2017, American journal of medical genetics. Part A.
[9] R. Mao,et al. BCAP31 Mutation Causing a Syndrome of Congenital Dystonia, Facial Dysorphism and Central Hypomyelination Discovered Using Exome Sequencing , 2016, Movement disorders clinical practice.
[10] C. Rosenberg,et al. Genomic copy number alterations in non‐syndromic hearing loss , 2015, Clinical genetics.
[11] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[12] H. Osaka,et al. Genotype–phenotype correlation of contiguous gene deletions of SLC6A8, BCAP31 and ABCD1 , 2015, Clinical Genetics.
[13] G. Raymond,et al. Distal Xq28 microdeletions: Clarification of the spectrum of contiguous gene deletions involving ABCD1, BCAP31, and SLC6A8 with a new case and review of the literature , 2014, American journal of medical genetics. Part A.
[14] Heidi L Rehm,et al. American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss , 2014, Genetics in Medicine.
[15] M. Lathrop,et al. Mutations in BCAP31 cause a severe X-linked phenotype with deafness, dystonia, and central hypomyelination and disorganize the Golgi apparatus. , 2013, American journal of human genetics.
[16] M. Mizuguchi,et al. Contiguous ABCD1 DXS1357E deletion syndrome: Report of an autopsy case , 2013, Neuropathology : official journal of the Japanese Society of Neuropathology.
[17] A. Munnich,et al. Phenotype and genotype in 101 males with X-linked creatine transporter deficiency , 2013, Journal of Medical Genetics.
[18] N. Matsumoto,et al. Contiguous deletion of SLC6A8 and BAP31 in a patient with severe dystonia and sensorineural deafness. , 2012, Molecular genetics and metabolism.
[19] A. Helenius,et al. BAP31 and BiP are essential for dislocation of SV40 from the endoplasmic reticulum to the cytosol , 2011, Nature Cell Biology.
[20] S. High,et al. Differences in endoplasmic-reticulum quality control determine the cellular response to disease-associated mutants of proteolipid protein , 2009, Journal of Cell Science.
[21] David J Stephens,et al. Bap31 is an itinerant protein that moves between the peripheral endoplasmic reticulum (ER) and a juxtanuclear compartment related to ER-associated Degradation. , 2008, Molecular biology of the cell.
[22] A. Fulton,et al. X-linked creatine transporter defect: A report on two unrelated boys with a severe clinical phenotype , 2006, Journal of Inherited Metabolic Disease.
[23] G. Shore,et al. Bap29/31 Influences the Intracellular Traffic of MHC Class I Molecules1 , 2004, The Journal of Immunology.
[24] H. Moser,et al. Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders. , 2002, American journal of human genetics.
[25] V. Lennon,et al. Endoplasmic Reticulum Membrane-sorting Protein of Lymphocytes (BAP31) Is Highly Expressed in Neurons and Discrete Endocrine Cells , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[26] Jyoti S. Choudhary,et al. Proteomics Characterization of Abundant Golgi Membrane Proteins* , 2001, The Journal of Biological Chemistry.
[27] W. Annaert,et al. Export of Cellubrevin from the Endoplasmic Reticulum Is Controlled by BAP31 , 1997, The Journal of cell biology.
[28] B. Poll-The,et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management , 2012 .